Mr. Speaker, a study of the mortality rate among women who received cosmetic breast implants between 1974 and 1989 indicates that the suicide rate among these women is 75% higher than in the general population.
In light of this alarming statistic, does the Minister of Health still intend to support the use of cosmetic breast implants by approving the licence applications of Mentor and Inamed even though these companies withheld information from the U.S. Food and Drug Administration?
The Special Access Program, available only for particular situations, approved silicone gel implants for cosmetic surgery in 65% of the cases. This is unacceptable.
The minister must implement the recommendations of the Standing Committee on Health, tighten the rules of the Special Access Program, and put on hold his decision to approve the licences.